GSK's $1 bln share tender offer for Indian unit to start Feb 18
MUMBAI Feb 10 (Reuters) - GlaxoSmithKline Plc's (GSK) share tender offer worth $1 billion to raise its stake in the Indian unit will start on Feb 18th and end of March 5th, the manager to the offer said in a notice to the exchanges on Monday.
GSK plans to raise its stake to as much as 75 percent from 50.7 percent in GlaxoSmithKline Pharmaceutical through the offer, betting on an increase in healthcare spending in emerging markets.
The British parent company is looking to buy up to 20.6 million shares of the Indian unit at 3,100 rupees a share. Shares of GlaxoSmithKline Pharmaceutical ended up 0.3 percent at 2,981.90 rupees on Monday.
HSBC Holdings Plc is the issue manager.
- Thousands of Gaza civilians flee after Israeli warning |
- Three dead, two wounded in Pasadena, California shootings
- Teen survivor of Texas shootings says slain family members 'in much better place'
- Rape and murder of 13-year-old spark debate in junta-ruled Thailand
- One man killed as shell from Ukraine hits Russian border town: reports